Compagnie Financière et d'Investissement Delaval Labosanté – Trademark Portfolio
Entity Type: 16
Compagnie Financière et d'Investissement Delaval Labosanté holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include FRANCE BEBE. The owner is based in SAINT-JEAN-SUR-MAYENNE.
La Hyaule
SAINT-JEAN-SUR-MAYENNE 53240 , FR
Showing of trademarks Trademarks
Trademark Classifications
Compagnie Financière et d'Investissement Delaval Labosanté's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Compagnie Financière et d'Investissement Delaval Labosanté have?
Compagnie Financière et d'Investissement Delaval Labosanté has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Compagnie Financière et d'Investissement Delaval Labosanté file in?
Compagnie Financière et d'Investissement Delaval Labosanté files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Compagnie Financière et d'Investissement Delaval Labosanté's most well-known trademarks?
Compagnie Financière et d'Investissement Delaval Labosanté's registered trademark portfolio includes well-known marks such as FRANCE BEBE. These are among 1 currently registered trademark in the portfolio.
What is Compagnie Financière et d'Investissement Delaval Labosanté's trademark registration success rate?
Compagnie Financière et d'Investissement Delaval Labosanté has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.